Pan Huang, College of Nursing, Wenzhou Medical University, Wenzhou, Zhejiang, China,
J Nutr Health Aging. 2022;26(5):510-514. doi: 10.1007/s12603-022-1787-7.
More indications proved that diet might be involved in the telomere length, a marker of biological aging and chronic diseases. Copper is widely viewed as one of the essential elements in the diet. Therefore, this study aimed to evaluate the relationship between telomere length and dietary copper intake in hypertension and provide a basis for guiding dietary copper intake in patients with hypertension.
The data was collected from the National Health and Nutrition Examination Survey (NHANES) in 1999-2000 and 2001-2002. The relevance between telomere length and dietary copper intake in hypertension is assessed using a multivariable linear regression model.
We gathered 1,867 participants with hypertension with assessed telomere length and dietary copper intake. We found that one unit increasing log-transformed dietary copper intake in hypertension was significantly associated with longer telomere length base pair (bp) (β = 112.20, 95% confidence interval [CI]: 5.48, 218.92), after controlling for covariates, including age, sex, ethnicity, body mass index (BMI), physical activity, and taking medication for hypertension. For the age group, we found that one unit increasing log-transformed dietary copper in hypertension was associated with longer telomere length (β = 237.95, 95% CI: 114.39, 361.51) in the age group >45 years. The grouping was based on whether the participants take medication for hypertension. We found that one unit increasing log-transformed dietary copper in hypertension was associated with longer telomere length (β = 116.47, 95% CI: 0.72, 232.21) in the group that takes medication for hypertension.
This study demonstrates that dietary copper intake was associated with longer telomere length in patients with hypertension, which provides evidence for guiding dietary copper intake in patients with hypertension. However, further studies are needed to evaluate the effect of copper supplementation on telomere length in patients with hypertension in well-designed random control studies and prospective studies.
越来越多的证据表明,饮食可能与端粒长度有关,端粒长度是生物衰老和慢性疾病的一个标志物。铜被广泛认为是饮食中的必需元素之一。因此,本研究旨在评估高血压患者端粒长度与膳食铜摄入量之间的关系,并为指导高血压患者膳食铜摄入量提供依据。
本研究的数据来自于 1999-2000 年和 2001-2002 年的全国健康和营养调查(NHANES)。使用多变量线性回归模型评估高血压患者端粒长度与膳食铜摄入量之间的相关性。
本研究共纳入了 1867 名高血压患者,评估了他们的端粒长度和膳食铜摄入量。我们发现,高血压患者膳食铜摄入量每增加一个对数单位,端粒长度就会增加 112.20 个碱基对(bp)(β=112.20,95%置信区间[CI]:5.48,218.92),在控制了年龄、性别、种族、体重指数(BMI)、身体活动和服用高血压药物等因素后。对于年龄组,我们发现高血压患者膳食铜摄入量每增加一个对数单位,与年龄>45 岁的患者端粒长度增加 237.95bp 相关(β=237.95,95%CI:114.39,361.51)。分组是基于患者是否服用高血压药物。我们发现,高血压患者膳食铜摄入量每增加一个对数单位,与服用高血压药物的患者端粒长度增加 116.47bp 相关(β=116.47,95%CI:0.72,232.21)。
本研究表明,高血压患者膳食铜摄入量与端粒长度有关,为指导高血压患者膳食铜摄入量提供了依据。然而,需要进一步的研究来评估在设计良好的随机对照研究和前瞻性研究中,铜补充剂对高血压患者端粒长度的影响。